Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in colorectal polypectomy
NCT01549418Phase 4Unknown
- Sponsor
- Maria Skłodowska-Curie National Research Institute of Oncology
- Start
- Sep 2012
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial in cardiovascular diseases (CVD) comparing Aspirin with Placebo (2 arms). Primary endpoint: Clinically significant bleeding after colorectal polypectomy at 30 days. Status: unknown.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT01549418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549418.